QbDVision is a breakthrough product lifecycle management platform for biopharma organizations.
It's the first and only solution that enables teams to transform fragmented data and siloed knowledge into true process intelligence: the smart, holistic guidance you need to accelerate new products to patients.
With QbDVision:
- You know where to find everything you need to streamline product development: in a structured framework that helps your teams work smarter, faster, and more collaboratively than ever.
- You know how to build robust, agile processes that your teams fully understand and control.
- You know why every input produces its output, and where they may lead to product and process risks.
You can see these benefits at work in several fully modernized solutions that QbDVision delivers for today’s drug development cycle: Automated reporting, risk-based traceability, all-in-one functionality, and process continuity.
It's the first and only solution that enables teams to transform fragmented data and siloed knowledge into true process intelligence: the smart, holistic guidance you need to accelerate new products to patients.
With QbDVision:
- You know where to find everything you need to streamline product development: in a structured framework that helps your teams work smarter, faster, and more collaboratively than ever.
- You know how to build robust, agile processes that your teams fully understand and control.
- You know why every input produces its output, and where they may lead to product and process risks.
You can see these benefits at work in several fully modernized solutions that QbDVision delivers for today’s drug development cycle: Automated reporting, risk-based traceability, all-in-one functionality, and process continuity.
Location: United States, Texas, Austin
Employees: 11-50
Total raised: $28M
Founded date: 2017
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.05.2025 | - | $13M | - |
| 15.02.2022 | Series A | $15M | - |
Mentions in press and media 4
| Date | Title | Description |
| 01.05.2025 | QbDVision Raises $13M in Financing | QbDVision, Inc., an Austin, TX-based Digital CMC platform (Chemistry, Manufacturing, and Controls) for the life sciences industry, closed a $13m financing, bringing the total of its Series A funding to $28m. The funding was co-led by Northp... |
| 15.02.2022 | QbDVision Raises $15M in Series A Funding | QbDVision, an Austin, TX-based SaaS solution purpose-built for drug lifecycle management provider, raised $15M in Series A funding. The round was led by Northpond Ventures, with participation from S3 Ventures, Wanxiang Healthcare Investment... |
| 16.06.2016 | Phoenix Group & Arkin Holdings to Invest $60M in Pharma & Biotech Companies | Phoenix Group (TASE: PHOE), one of Israel’s largest insurance and finance companies, and Arkin Holdings, an investment entity specializing in the life science field, have teamed up to invest in pharma and biotech companies. The approx. $60m... |
| - | QbDVision | “QbDVision's digital CMC software for pharma & biotech accelerates drug development by transforming dispersed data & knowledge to process intelligence.” |